MedTrace Logo

Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products

NCT02731105 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-10-23

No results posted yet for this study

Summary

Study to compare two gels that are used to treat acne vulgaris. It will be compared the tolerability and effectivity following application of two combination topical acne products clindamycin 1% and 0.025% tretinoin gel (Acnatac® Gel), adapalen 0,1% and benzoyl peroxide 2,5% gel (Epiduo® Gel).

Conditions

  • Acne Vulgaris

Interventions

DRUG

Acnatac® Gel left face

topical application

DRUG

Epiduo® Gel right face

topical application

DRUG

Acnatac® Gel right face

topical application

DRUG

Epiduo® Gel left face

topical application

Sponsors & Collaborators

  • GWT-TUD GmbH

    lead OTHER

Principal Investigators

  • Roland Aschoff, MD · Uniklinikum Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-02-21
Completion
2018-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02731105 on ClinicalTrials.gov